Delivery Order SPE2DB20D3104-SPE2DB23FV7C9

Award Date 6/5/23
Potential Completion Date 6/6/23
Potential Value $3.5K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under an Indefinite Delivery Contract (IDC) with a potential value of $28,215.71. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is for the delivery of 4,563,004,072 units of Ondansetron HCL 4 mg Tablets. This contract is part of a larger IDC held by Cencora, Inc. with the DLA, valued at up to $999,999,999.00, which serves as the primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,685.40, is a firm-fixed-price delivery order with a completion date of February 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,331.74 firm-fixed-price delivery order covers the supply of Ondansetron ODT 4 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which Cencora, Inc. holds with the DLA Troop Support Medical. The IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Ondansetron ODT 4 mg tablets. The $1,519.85 firm-fixed-price delivery order was placed by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency that procures medical supplies. The award is not associated with any set-aside program. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $10,923.88 firm-fixed-price delivery order is for the supply of Ondansetron ODT 4 mg tablets to support military healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999 and running through November 2026. This IDC serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp., a subsidiary of Cencora, Inc., is for the delivery of Ondansetron HCL 8 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $4,376.92 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC, which runs through November 2026, serves as the primary vehicle for Cencora, Inc. to...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Ondansetron ODT 4 mg tablets. The award, valued at $7,649.00, was made by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). The contract is a delivery order with a firm fixed price, and the ultimate completion date is December 5, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $6,372.60, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $8,070.68 firm-fixed-price delivery order is for the supply of 4 mg Ondansetron HCl tablets. This award is part of a larger Indefinite Delivery Contract (IDC) between the DLA and Cencora, Inc., valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical...
This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $11,179.76, is a Firm Fixed Price Delivery Order for the supply of Ondansetron ODT 8 mg Tablets. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Cencora, Inc. with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB23FV7C9
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) for the delivery of Ondansetron ODT 4 mg tablets. The $3,532.55 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This award demonstrates Amerisourcebergen's role as a critical supplier of essential medications and medical commodities to the U.S. Department of Defense and other federal healthcare programs.

Generated 2/27/25, 10:40 AM